Personal information
Biography
Francesca currently serves as a Project Manager at the FNIH (Foundation for the National Institutes of Health), where she leads a groundbreaking Alzheimer's project. Leveraging her extensive background and expertise in neuroscience therapeutics, Francesca is spearheading efforts to advance our understanding and develop innovative solutions for Alzheimer's disease.
Before joining the FNIH, Francesca held a position at Dolby Family Ventures, an early-stage venture firm that focuses on investing in companies in the technology and life sciences sectors. At Dolby Family Ventures, Francesca concentrated on novel neuroscience therapeutics, therapeutics for clinical depression, and neuromodulation/neurostimulation.
Prior to her role at Dolby Family Ventures, Francesca served as a senior scientist at Alector, where she contributed to various pipeline programs in the neuroimmunology/neurodegeneration space, including the research on TREM2, and led an early-stage target discovery program during her time at Alector.
Francesca's academic journey includes a Postdoc at Washington University in St. Louis, where she conducted research on neurodegeneration, with a specific focus on Multiple Sclerosis and Alzheimer's disease. She also served as a consultant for the Biotechnology and Life Sciences Advising (BALSA) Group during her time at Washington University.
Before pursuing her career in the United States, Francesca was a fellow at San Raffaele University in Milan, Italy, where she explored the relationship between iron and neurodegeneration.
She holds a Ph.D. in Microbiology from the University of Brescia in Italy, and prior to that, she earned an MS in Medical Biotechnology, with honors, and a BS in Biotechnology, both from the same university.
Activities
Employment (4)
Education and qualifications (3)
Works (10)
PPR8668